PDB Short entry for 5FBN HEADER TRANSFERASE 14-DEC-15 5FBN TITLE BTK KINASE DOMAIN WITH INHIBITOR 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: C, D; COMPND 4 FRAGMENT: UNP RESIDUES 389-659; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.C.A.RAAIJMAKERS,D.VU-PHAM REVDAT 3 24-APR-19 5FBN 1 SOURCE REVDAT 2 30-MAR-16 5FBN 1 JRNL REVDAT 1 03-FEB-16 5FBN 0 JRNL AUTH J.LIU,D.GUIADEEN,A.KRIKORIAN,X.GAO,J.WANG,S.B.BOGA, JRNL AUTH 2 A.B.ALHASSAN,Y.YU,H.VACCARO,S.LIU,C.YANG,H.WU,A.COOPER, JRNL AUTH 3 J.DE MAN,A.KAPTEIN,K.MALONEY,V.HORNAK,Y.D.GAO,T.O.FISCHMANN, JRNL AUTH 4 H.RAAIJMAKERS,D.VU-PHAM,J.PRESLAND,M.MANSUETO,Z.XU, JRNL AUTH 5 E.LECCESE,J.ZHANG-HOOVER,I.KNEMEYER,C.G.GARLISI,N.BAYS, JRNL AUTH 6 P.STIVERS,P.E.BRANDISH,A.HICKS,R.KIM,J.A.KOZLOWSKI JRNL TITL DISCOVERY OF 8-AMINO-IMIDAZO[1,5-A]PYRAZINES AS REVERSIBLE JRNL TITL 2 BTK INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. JRNL REF ACS MED.CHEM.LETT. V. 7 198 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 26985298 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00463 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 103.05 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 45481 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.800 REMARK 3 FREE R VALUE TEST SET COUNT : 3322 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2405 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.3330 REMARK 3 BIN FREE R VALUE SET COUNT : 167 REMARK 3 BIN FREE R VALUE : 0.3980 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4171 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 234 REMARK 3 SOLVENT ATOMS : 517 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.29000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : 0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.150 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.141 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.989 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4633 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4272 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6297 ; 1.748 ; 2.014 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9836 ; 1.317 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 531 ; 6.291 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 208 ;35.682 ;23.942 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 803 ;13.566 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;13.256 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 635 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5175 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1107 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2096 ; 0.900 ; 1.292 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2095 ; 0.897 ; 1.291 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2635 ; 1.540 ; 1.925 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2636 ; 1.539 ; 1.926 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2537 ; 1.191 ; 1.535 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2537 ; 1.191 ; 1.535 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3639 ; 1.945 ; 2.238 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5919 ; 5.386 ;12.433 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5920 ; 5.386 ;12.436 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 C 395 658 D 395 658 67594 0.09 0.05 REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.955 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H,-K,L REMARK 3 TWIN FRACTION : 0.045 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 395 C 1000 REMARK 3 ORIGIN FOR THE GROUP (A): -14.1350 29.5110 -9.3250 REMARK 3 T TENSOR REMARK 3 T11: 0.0116 T22: 0.1184 REMARK 3 T33: 0.0073 T12: 0.0020 REMARK 3 T13: 0.0078 T23: 0.0011 REMARK 3 L TENSOR REMARK 3 L11: 0.7647 L22: 0.7555 REMARK 3 L33: 1.7366 L12: 0.0349 REMARK 3 L13: -0.0276 L23: 0.1838 REMARK 3 S TENSOR REMARK 3 S11: -0.0335 S12: 0.0887 S13: 0.0117 REMARK 3 S21: -0.0829 S22: 0.0276 S23: -0.0710 REMARK 3 S31: 0.0237 S32: 0.1136 S33: 0.0059 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 394 D 1000 REMARK 3 ORIGIN FOR THE GROUP (A): -13.3170 1.1510 -42.5330 REMARK 3 T TENSOR REMARK 3 T11: 0.0075 T22: 0.1027 REMARK 3 T33: 0.0066 T12: -0.0056 REMARK 3 T13: -0.0062 T23: -0.0026 REMARK 3 L TENSOR REMARK 3 L11: 1.1180 L22: 0.5986 REMARK 3 L33: 1.7595 L12: 0.0123 REMARK 3 L13: -0.2237 L23: -0.0386 REMARK 3 S TENSOR REMARK 3 S11: 0.0169 S12: -0.1231 S13: -0.0352 REMARK 3 S21: 0.0657 S22: -0.0158 S23: -0.0543 REMARK 3 S31: -0.0097 S32: 0.1416 S33: -0.0010 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5FBN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000215967. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0-6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48820 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 36.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NOT DEPOSITED INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% V/V PEG 20000 0.1M NACL 0.1M NA REMARK 280 MES PH 6.5 2.5 MM MM (S)-4-(8-AMINO-3-(1-(4-(DIMETHYLAMINO) REMARK 280 BUTANOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(THIAZOL- REMARK 280 2-YL)BENZAMIDE 5.0 MM (R)-4-(8-AMINO-3-(1-(3-METHYLOXETANE-3- REMARK 280 CARBONYL)PIPERIDIN-3-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(4- REMARK 280 (TRIFLUOROMETHYL)PYRIDIN-2-YL)BENZAMIDE, PH 5.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.73750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY C 389 REMARK 465 LEU C 390 REMARK 465 GLY C 391 REMARK 465 TYR C 392 REMARK 465 GLY C 393 REMARK 465 SER C 394 REMARK 465 ASP C 549 REMARK 465 GLU C 550 REMARK 465 TYR C 551 REMARK 465 THR C 552 REMARK 465 SER C 553 REMARK 465 SER C 554 REMARK 465 VAL C 555 REMARK 465 GLY C 556 REMARK 465 SER C 659 REMARK 465 GLY D 389 REMARK 465 LEU D 390 REMARK 465 GLY D 391 REMARK 465 TYR D 392 REMARK 465 GLY D 393 REMARK 465 ASP D 549 REMARK 465 GLU D 550 REMARK 465 TYR D 551 REMARK 465 THR D 552 REMARK 465 SER D 553 REMARK 465 SER D 554 REMARK 465 VAL D 555 REMARK 465 GLY D 556 REMARK 465 SER D 557 REMARK 465 LYS D 558 REMARK 465 SER D 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN C 412 CD OE1 NE2 REMARK 470 GLU C 434 CD OE1 OE2 REMARK 470 LYS C 447 CD CE NZ REMARK 470 GLU C 455 CD OE1 OE2 REMARK 470 GLN C 496 CD OE1 NE2 REMARK 470 ASP C 548 C O CB CG OD1 OD2 REMARK 470 LYS C 558 CD CE NZ REMARK 470 LYS C 637 CE NZ REMARK 470 LYS D 406 CE NZ REMARK 470 LYS D 447 CD CE NZ REMARK 470 GLU D 455 CD OE1 OE2 REMARK 470 LYS D 466 CE NZ REMARK 470 ASP D 548 C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU C 513 O HOH C 801 1.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU D 599 CG GLU D 599 CD 0.097 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 492 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG D 492 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ASP D 521 CB - CG - OD2 ANGL. DEV. = 6.6 DEGREES REMARK 500 GLU D 599 OE1 - CD - OE2 ANGL. DEV. = -7.4 DEGREES REMARK 500 ARG D 615 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 MET D 655 CG - SD - CE ANGL. DEV. = -9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE C 413 -14.63 83.42 REMARK 500 GLN C 424 -45.35 -138.72 REMARK 500 ARG C 520 -24.42 86.66 REMARK 500 ARG C 520 -24.05 86.66 REMARK 500 ASP C 521 48.73 -142.89 REMARK 500 ASP C 521 47.95 -143.08 REMARK 500 LYS C 558 -31.01 143.31 REMARK 500 PHE D 413 -16.42 84.68 REMARK 500 GLN D 424 -46.96 -139.01 REMARK 500 ARG D 520 -26.38 86.04 REMARK 500 ARG D 520 -20.34 86.04 REMARK 500 ASP D 521 46.45 -140.12 REMARK 500 ASP D 521 35.23 -144.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D1076 DISTANCE = 6.20 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 5WE C 702 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WF C 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WE C 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL D 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WF D 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WE D 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WE D 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5WE D 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO D 706 DBREF 5FBN C 389 659 UNP Q06187 BTK_HUMAN 389 659 DBREF 5FBN D 389 659 UNP Q06187 BTK_HUMAN 389 659 SEQRES 1 C 271 GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP SEQRES 2 C 271 LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY SEQRES 3 C 271 VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL SEQRES 4 C 271 ALA ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP SEQRES 5 C 271 GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER SEQRES 6 C 271 HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS SEQRES 7 C 271 GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN SEQRES 8 C 271 GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG SEQRES 9 C 271 PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL SEQRES 10 C 271 CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU SEQRES 11 C 271 HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP SEQRES 12 C 271 GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 13 C 271 TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER SEQRES 14 C 271 LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET SEQRES 15 C 271 TYR SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE SEQRES 16 C 271 GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET SEQRES 17 C 271 PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS SEQRES 18 C 271 ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SEQRES 19 C 271 SER GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS SEQRES 20 C 271 GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SEQRES 21 C 271 SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER SEQRES 1 D 271 GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP SEQRES 2 D 271 LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY SEQRES 3 D 271 VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL SEQRES 4 D 271 ALA ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP SEQRES 5 D 271 GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER SEQRES 6 D 271 HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS SEQRES 7 D 271 GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN SEQRES 8 D 271 GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG SEQRES 9 D 271 PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL SEQRES 10 D 271 CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU SEQRES 11 D 271 HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP SEQRES 12 D 271 GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 13 D 271 TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER SEQRES 14 D 271 LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET SEQRES 15 D 271 TYR SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE SEQRES 16 D 271 GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET SEQRES 17 D 271 PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS SEQRES 18 D 271 ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SEQRES 19 D 271 SER GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS SEQRES 20 D 271 GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SEQRES 21 D 271 SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET 5WF C 701 42 HET 5WE C 702 33 HET CL C 703 1 HET CL D 701 1 HET 5WF D 702 42 HET 5WE D 703 37 HET 5WE D 704 37 HET 5WE D 705 37 HET EDO D 706 4 HETNAM 5WF 4-[8-AZANYL-3-[(3~{R})-1-(3-METHYLOXETAN-3-YL) HETNAM 2 5WF CARBONYLPIPERIDIN-3-YL]IMIDAZO[1,5-A]PYRAZIN-1-YL]- HETNAM 3 5WF ~{N}-[4-(TRIFLUOROMETHYL)PYRIDIN-2-YL]BENZAMIDE HETNAM 5WE 4-[8-AZANYL-3-[(2~{S})-1-[4-(DIMETHYLAMINO) HETNAM 2 5WE BUTANOYL]PYRROLIDIN-2-YL]IMIDAZO[1,5-A]PYRAZIN-1-YL]- HETNAM 3 5WE ~{N}-(1,3-THIAZOL-2-YL)BENZAMIDE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 5WF 2(C29 H28 F3 N7 O3) FORMUL 4 5WE 4(C26 H30 N8 O2 S) FORMUL 5 CL 2(CL 1-) FORMUL 11 EDO C2 H6 O2 FORMUL 12 HOH *517(H2 O) HELIX 1 AA1 ASP C 398 LYS C 400 5 3 HELIX 2 AA2 SER C 438 MET C 450 1 13 HELIX 3 AA3 LEU C 482 GLU C 488 1 7 HELIX 4 AA4 MET C 489 ARG C 492 5 4 HELIX 5 AA5 GLN C 494 LYS C 515 1 22 HELIX 6 AA6 ALA C 523 ARG C 525 5 3 HELIX 7 AA7 GLY C 541 VAL C 546 5 6 HELIX 8 AA8 PRO C 560 SER C 564 5 5 HELIX 9 AA9 PRO C 565 SER C 572 1 8 HELIX 10 AB1 SER C 575 SER C 592 1 18 HELIX 11 AB2 THR C 602 GLN C 612 1 11 HELIX 12 AB3 SER C 623 CYS C 633 1 11 HELIX 13 AB4 LYS C 637 ARG C 641 5 5 HELIX 14 AB5 THR C 643 GLU C 658 1 16 HELIX 15 AB6 ASP D 398 LYS D 400 5 3 HELIX 16 AB7 SER D 438 MET D 450 1 13 HELIX 17 AB8 LEU D 482 GLU D 488 1 7 HELIX 18 AB9 MET D 489 ARG D 492 5 4 HELIX 19 AC1 GLN D 494 LYS D 515 1 22 HELIX 20 AC2 ALA D 523 ARG D 525 5 3 HELIX 21 AC3 GLY D 541 VAL D 546 5 6 HELIX 22 AC4 PRO D 560 SER D 564 5 5 HELIX 23 AC5 PRO D 565 SER D 572 1 8 HELIX 24 AC6 SER D 575 SER D 592 1 18 HELIX 25 AC7 THR D 602 GLN D 612 1 11 HELIX 26 AC8 SER D 623 CYS D 633 1 11 HELIX 27 AC9 LYS D 637 ARG D 641 5 5 HELIX 28 AD1 THR D 643 GLU D 658 1 16 SHEET 1 AA1 5 LEU C 402 GLY C 411 0 SHEET 2 AA1 5 GLY C 414 TRP C 421 -1 O TYR C 418 N LYS C 406 SHEET 3 AA1 5 TYR C 425 ILE C 432 -1 O MET C 431 N VAL C 415 SHEET 4 AA1 5 PHE C 471 THR C 474 -1 O THR C 474 N ALA C 428 SHEET 5 AA1 5 LEU C 460 CYS C 464 -1 N GLY C 462 O ILE C 473 SHEET 1 AA2 3 GLY C 480 CYS C 481 0 SHEET 2 AA2 3 CYS C 527 VAL C 529 -1 O VAL C 529 N GLY C 480 SHEET 3 AA2 3 VAL C 535 VAL C 537 -1 O LYS C 536 N LEU C 528 SHEET 1 AA3 5 LEU D 402 GLY D 411 0 SHEET 2 AA3 5 GLY D 414 TRP D 421 -1 O TYR D 418 N LYS D 406 SHEET 3 AA3 5 TYR D 425 ILE D 432 -1 O MET D 431 N VAL D 415 SHEET 4 AA3 5 PHE D 471 THR D 474 -1 O ILE D 472 N LYS D 430 SHEET 5 AA3 5 LEU D 460 CYS D 464 -1 N GLY D 462 O ILE D 473 SHEET 1 AA4 3 GLY D 480 CYS D 481 0 SHEET 2 AA4 3 CYS D 527 VAL D 529 -1 O VAL D 529 N GLY D 480 SHEET 3 AA4 3 VAL D 535 VAL D 537 -1 O LYS D 536 N LEU D 528 CISPEP 1 ARG C 468 PRO C 469 0 1.44 CISPEP 2 ARG D 468 PRO D 469 0 -0.88 SITE 1 AC1 20 LEU C 408 ALA C 428 LYS C 430 PHE C 442 SITE 2 AC1 20 MET C 449 MET C 450 LEU C 460 ILE C 472 SITE 3 AC1 20 THR C 474 GLU C 475 MET C 477 GLY C 480 SITE 4 AC1 20 CYS C 481 ASN C 484 SER C 538 ASP C 539 SITE 5 AC1 20 PHE C 540 LEU C 542 HOH C 907 HOH C 918 SITE 1 AC2 10 TRP C 421 TYR C 425 SER C 453 TYR C 461 SITE 2 AC2 10 HOH C 817 HOH C 873 HOH C 906 HOH C 927 SITE 3 AC2 10 HOH C 946 5WE D 703 SITE 1 AC3 4 GLU C 407 GLY C 409 VAL C 416 LYS C 417 SITE 1 AC4 3 ARG D 618 5WE D 704 5WE D 705 SITE 1 AC5 20 LEU D 408 VAL D 416 ALA D 428 LYS D 430 SITE 2 AC5 20 PHE D 442 MET D 449 LEU D 460 ILE D 472 SITE 3 AC5 20 THR D 474 GLU D 475 MET D 477 GLY D 480 SITE 4 AC5 20 CYS D 481 ASN D 484 SER D 538 ASP D 539 SITE 5 AC5 20 PHE D 540 LEU D 542 HOH D 888 HOH D 909 SITE 1 AC6 9 5WE C 702 TRP D 421 TYR D 425 SER D 453 SITE 2 AC6 9 GLN D 459 TYR D 461 HOH D 808 HOH D 839 SITE 3 AC6 9 HOH D 915 SITE 1 AC7 5 GLU D 624 CL D 701 5WE D 705 HOH D 857 SITE 2 AC7 5 HOH D 903 SITE 1 AC8 11 ARG D 618 GLU D 624 TYR D 627 THR D 628 SITE 2 AC8 11 TYR D 631 CL D 701 5WE D 704 HOH D 901 SITE 3 AC8 11 HOH D 903 HOH D 949 HOH D 953 SITE 1 AC9 3 THR D 403 PHE D 404 HOH D 978 CRYST1 38.262 71.475 103.056 90.00 90.68 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026135 0.000000 0.000311 0.00000 SCALE2 0.000000 0.013991 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009704 0.00000